<DOC>
	<DOCNO>NCT02019433</DOCNO>
	<brief_summary>Implant Survival well clinical radiological Follow-Up acetabular Titan-Augment Structan®</brief_summary>
	<brief_title>Post Market Clinical Follow-Up Acetabular Titan-Augment Structan®</brief_title>
	<detailed_description />
	<criteria>Minimum age 18 year Indication cementless hip arthroplasty acetabular defect need Allograft titanium augment Patient consent study participation Physical mental willingness participate followup Patient available followup Increased anesthetic risk patient accord `` American Society Anesthesiology '' : ASA IV Tumor Alcohol Drug abuse Permanent cortisone therapy Clinically relevant infection ( Planned ) pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>THA , augment , revision , pelvis</keyword>
</DOC>